NCT06868238 2026-02-18
Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)
University of Florida
Phase 2 Withdrawn
Clinical Trials
9 trialsNCT06092892 2025-12-10
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
Cedars-Sinai Medical Center
Phase 2 Recruiting
NCT03658967 2025-07-09
AdeLE
Herantis Pharma Plc.
Phase 2 Completed
NCT01276054 2014-08-01
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
University of Southern California
Phase 2 Terminated
NCT00077090 2013-12-18
Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00022204 2013-11-06
Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01003951 2012-08-16
Acupuncture for the Treatment of Chronic Lymphedema
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01318785 2011-09-07
BF09-PH-01
University Medicine Greifswald
Phase 2 Unknown
NCT00188604 2010-08-13
The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer
University Health Network, Toronto
Phase 2 Completed